Research shows that a daily, combined dose of estrogen and progestin increases breast cancer risk in post menopausal women; the risk begins to return to normal about six months after women stop taking the hormones. The analysis was part of the National Institute of Child Health and Human Development (NICHD) Women’s Contraceptive and Reproductive Experiences...
To access this content, you must purchase Annual Membership or Monthly Membership, or log in if you are a member.
